$43.69
0.270.62%
At close: -
$43.69
0.000.00%
After Hours: May 2, 4:00 PM EDT
Comments
Loading...
Mirum Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:MIRM | Benzinga
Mirum Pharmaceuticals Inc has a consensus price target of $57.69 based on the ratings of 16 analysts. The high is $74 issued by Citizens Capital Markets on February 24, 2025. The low is $38 issued by Citigroup on May 9, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Baird, and Citizens Capital Markets on February 28, 2025, February 27, 2025, and February 24, 2025, respectively. With an average price target of $67 between HC Wainwright & Co., Baird, and Citizens Capital Markets, there's an implied 53.35% upside for Mirum Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Baird
Citizens Capital Markets
Citigroup
Leerink Partners
1calculated from analyst ratings
Analyst Ratings for Mirum Pharmaceuticals
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 02/28/2025 | Buy Now | 64.8% | HC Wainwright & Co. | Ed Arce60% | $66 → $72 | Maintains | Buy | Get Alert |
| 02/27/2025 | Buy Now | 25.89% | Baird | Brian Skorney58% | $50 → $55 | Maintains | Outperform | Get Alert |
| 02/24/2025 | Buy Now | 69.38% | Citizens Capital Markets | Jonathan Wolleben69% | $74 → $74 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 11/13/2024 | Buy Now | 51.06% | HC Wainwright & Co. | Ed Arce60% | $66 → $66 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | Buy Now | 55.64% | Citigroup | David Lebowitz52% | $65 → $68 | Maintains | Buy | Get Alert |
| 11/13/2024 | Buy Now | 14.44% | Baird | Brian Skorney58% | $44 → $50 | Maintains | Outperform | Get Alert |
| 10/17/2024 | Buy Now | 12.15% | Leerink Partners | Mani Foroohar49% | $47 → $49 | Maintains | Outperform | Get Alert |
| 10/11/2024 | Buy Now | 51.06% | HC Wainwright & Co. | Ed Arce60% | $66 → $66 | Reiterates | Buy → Buy | Get Alert |
| 08/08/2024 | Buy Now | 37.33% | Cantor Fitzgerald | Josh Schimmer56% | $50 → $60 | Maintains | Overweight | Get Alert |
| 08/08/2024 | Buy Now | 51.06% | Evercore ISI Group | Gavin Clark-Gartner42% | $62 → $66 | Maintains | Outperform | Get Alert |
| 08/08/2024 | Buy Now | 0.71% | Baird | Brian Skorney58% | $39 → $44 | Maintains | Outperform | Get Alert |
| 07/26/2024 | Buy Now | 51.06% | HC Wainwright & Co. | Ed Arce60% | $66 → $66 | Reiterates | Buy → Buy | Get Alert |
| 07/08/2024 | Buy Now | 51.06% | HC Wainwright & Co. | Ed Arce60% | $66 → $66 | Reiterates | Buy → Buy | Get Alert |
| 06/28/2024 | Buy Now | 51.06% | HC Wainwright & Co. | Ed Arce60% | $66 → $66 | Reiterates | Buy → Buy | Get Alert |
| 06/20/2024 | Buy Now | 51.06% | Stifel | Dae Gon Ha48% | $48 → $66 | Maintains | Buy | Get Alert |
| 06/18/2024 | Buy Now | 46.49% | Citigroup | David Lebowitz52% | $38 → $64 | Maintains | Buy | Get Alert |
| 06/18/2024 | Buy Now | -10.73% | JP Morgan | Jessica Fye67% | $31 → $39 | Maintains | Overweight | Get Alert |
| 06/18/2024 | Buy Now | 55.64% | JMP Securities | Jonathan Wolleben69% | $66 → $68 | Maintains | Market Outperform | Get Alert |
| 06/18/2024 | Buy Now | 30.46% | Morgan Stanley | Michael Ulz63% | $53 → $57 | Maintains | Overweight | Get Alert |
| 06/17/2024 | Buy Now | 51.06% | HC Wainwright & Co. | Ed Arce60% | $58 → $66 | Maintains | Buy | Get Alert |
| 06/17/2024 | Buy Now | 9.86% | Stifel | Dae Gon Ha48% | $48 → $48 | Reiterates | Buy → Buy | Get Alert |
| 06/17/2024 | Buy Now | -10.73% | Baird | Brian Skorney58% | $34 → $39 | Maintains | Outperform | Get Alert |
| 06/07/2024 | Buy Now | 32.75% | HC Wainwright & Co. | Ed Arce60% | $58 → $58 | Reiterates | Buy → Buy | Get Alert |
| 06/03/2024 | Buy Now | 32.75% | HC Wainwright & Co. | — | $58 → $58 | Reiterates | Buy → Buy | Get Alert |
| 05/10/2024 | Buy Now | 21.31% | Morgan Stanley | Michael Ulz63% | $57 → $53 | Maintains | Overweight | Get Alert |
| 05/09/2024 | Buy Now | -8.45% | Cantor Fitzgerald | Josh Schimmer56% | $40 → $40 | Reiterates | Overweight → Overweight | Get Alert |
| 05/09/2024 | Buy Now | 32.75% | HC Wainwright & Co. | Ed Arce60% | $58 → $58 | Reiterates | Buy → Buy | Get Alert |
| 05/09/2024 | Buy Now | 51.06% | JMP Securities | Jonathan Wolleben69% | $72 → $66 | Maintains | Market Outperform | Get Alert |
| 05/09/2024 | Buy Now | -13.02% | Citigroup | David Lebovitz65% | $37 → $38 | Maintains | Buy | Get Alert |
| 04/17/2024 | Buy Now | 9.86% | Stifel | Dae Gon Ha48% | → $48 | Initiates | → Buy | Get Alert |
| 04/02/2024 | Buy Now | 32.75% | HC Wainwright & Co. | Ed Arce60% | $58 → $58 | Maintains | Buy | Get Alert |
| 03/18/2024 | Buy Now | -1.58% | Leerink Partners | Mani Foroohar49% | $44 → $43 | Maintains | Outperform | Get Alert |
| 03/14/2024 | Buy Now | 64.8% | JMP Securities | Jonathan Wolleben69% | $69 → $72 | Maintains | Outperform | Get Alert |
| 03/14/2024 | Buy Now | 32.75% | HC Wainwright & Co. | Ed Arce60% | $45 → $58 | Maintains | Buy | Get Alert |
| 03/04/2024 | Buy Now | -8.45% | Cantor Fitzgerald | Josh Schimmer56% | $35 → $40 | Maintains | Overweight | Get Alert |
| 02/29/2024 | Buy Now | -19.89% | Cantor Fitzgerald | Josh Schimmer56% | $35 → $35 | Reiterates | Overweight → Overweight | Get Alert |
| 02/29/2024 | Buy Now | 3% | HC Wainwright & Co. | Ed Arce60% | $58 → $45 | Maintains | Buy | Get Alert |
| 02/29/2024 | Buy Now | 57.93% | JMP Securities | Jonathan Wolleben69% | $64 → $69 | Maintains | Market Outperform | Get Alert |
| 01/11/2024 | Buy Now | 46.49% | JMP Securities | Jonathan Wolleben69% | $64 → $64 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/19/2023 | Buy Now | 46.49% | Raymond James | Steven Seedhouse59% | $78 → $64 | Maintains | Strong Buy | Get Alert |
| 12/18/2023 | Buy Now | 32.75% | HC Wainwright & Co. | Ed Arce60% | $60 → $58 | Maintains | Buy | Get Alert |
| 11/27/2023 | Buy Now | 14.44% | Cantor Fitzgerald | Josh Schimmer56% | → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 11/20/2023 | Buy Now | -15.31% | JP Morgan | Jessica Fye67% | → $37 | Reinstates | → Overweight | Get Alert |
| 11/15/2023 | Buy Now | 14.44% | Cantor Fitzgerald | Joshua Schimmer44% | → $50 | Reiterates | Overweight → Overweight | Get Alert |
| 11/13/2023 | Buy Now | 37.33% | Morgan Stanley | Michael Ulz63% | → $60 | Initiates | → Overweight | Get Alert |
| 11/03/2023 | Buy Now | 37.33% | HC Wainwright & Co. | Ed Arce60% | $63 → $60 | Maintains | Buy | Get Alert |
| 10/24/2023 | Buy Now | 14.44% | Cantor Fitzgerald | Joshua Schimmer44% | → $50 | Initiates | → Overweight | Get Alert |
| 10/18/2023 | Buy Now | 60.22% | JMP Securities | Jonathan Wolleben69% | → $70 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 10/18/2023 | Buy Now | 76.24% | Raymond James | Steven Seedhouse59% | $84 → $77 | Maintains | Strong Buy | Get Alert |
| 10/17/2023 | Buy Now | 41.91% | Evercore ISI Group | Gavin Clark-Gartner42% | → $62 | Reinstates | → Outperform | Get Alert |
| 10/09/2023 | Buy Now | 60.22% | JMP Securities | Jonathan Wolleben69% | → $70 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 09/20/2023 | Buy Now | 60.22% | JMP Securities | Jonathan Wolleben69% | → $70 | Initiates | → Market Outperform | Get Alert |
| 09/13/2023 | Buy Now | 44.2% | HC Wainwright & Co. | Ed Arce60% | → $63 | Reiterates | Buy → Buy | Get Alert |
| 08/21/2023 | Buy Now | 92.26% | Raymond James | Steven Seedhouse59% | $79 → $84 | Maintains | Strong Buy | Get Alert |
| 08/04/2023 | Buy Now | 44.2% | HC Wainwright & Co. | Ed Arce60% | → $63 | Reiterates | → Buy | Get Alert |
| 08/04/2023 | Buy Now | 80.82% | Raymond James | Steven Seedhouse59% | $82 → $79 | Maintains | Strong Buy | Get Alert |
| 07/18/2023 | Buy Now | 44.2% | HC Wainwright & Co. | Ed Arce60% | $61 → $63 | Maintains | Buy | Get Alert |
| 07/18/2023 | Buy Now | 87.69% | Raymond James | Steven Seedhouse59% | $81 → $82 | Maintains | Strong Buy | Get Alert |
| 06/15/2023 | Buy Now | 39.62% | HC Wainwright & Co. | Ed Arce60% | → $61 | Reiterates | Buy → Buy | Get Alert |
| 05/22/2023 | Buy Now | 39.62% | HC Wainwright & Co. | Ed Arce60% | → $61 | Reiterates | Buy → Buy | Get Alert |
| 05/05/2023 | Buy Now | 39.62% | HC Wainwright & Co. | Ed Arce60% | → $61 | Reiterates | → Buy | Get Alert |
| 04/13/2023 | Buy Now | 85.4% | Raymond James | Steven Seedhouse59% | $83 → $81 | Maintains | Strong Buy | Get Alert |
| 04/06/2023 | Buy Now | 39.62% | HC Wainwright & Co. | Ed Arce60% | → $61 | Reiterates | → Buy | Get Alert |
| 03/15/2023 | Buy Now | 39.62% | HC Wainwright & Co. | Ed Arce60% | → $61 | Reiterates | → Buy | Get Alert |
| 03/09/2023 | Buy Now | 39.62% | HC Wainwright & Co. | Ed Arce60% | → $61 | Reiterates | → Buy | Get Alert |
| 03/09/2023 | Buy Now | 89.97% | Raymond James | Steven Seedhouse59% | $84 → $83 | Maintains | Strong Buy | Get Alert |
| 02/15/2023 | Buy Now | 39.62% | HC Wainwright & Co. | Ed Arce60% | $69 → $61 | Reiterates | → Buy | Get Alert |
| 01/10/2023 | Buy Now | 92.26% | Raymond James | Steven Seedhouse59% | $88 → $84 | Maintains | Strong Buy | Get Alert |
| 01/10/2023 | Buy Now | -10.73% | SVB Leerink | Mani Foroohar49% | $50 → $39 | Maintains | Outperform | Get Alert |
| 12/14/2022 | Buy Now | 14.44% | SVB Leerink | Mani Foroohar49% | $49 → $50 | Maintains | Outperform | Get Alert |
| 11/14/2022 | Buy Now | 57.93% | HC Wainwright & Co. | Ed Arce60% | $68 → $69 | Maintains | Buy | Get Alert |
| 11/10/2022 | Buy Now | -22.18% | Citigroup | David Lebowitz52% | $38 → $34 | Maintains | Buy | Get Alert |
| 10/25/2022 | Buy Now | 101.42% | Raymond James | Steven Seedhouse59% | $75 → $88 | Maintains | Strong Buy | Get Alert |
| 10/25/2022 | Buy Now | 55.64% | HC Wainwright & Co. | Ed Arce60% | $63 → $68 | Maintains | Buy | Get Alert |
| 09/01/2022 | Buy Now | -13.02% | Citigroup | David Lebowitz52% | → $38 | Initiates | → Buy | Get Alert |
| 05/24/2022 | Buy Now | 19.02% | SVB Leerink | Mani Foroohar49% | $50 → $52 | Maintains | Outperform | Get Alert |
| 05/23/2022 | Buy Now | 57.93% | HC Wainwright & Co. | Ed Arce60% | $64 → $69 | Maintains | Buy | Get Alert |
| 05/06/2022 | Buy Now | 71.66% | Raymond James | Steven Seedhouse59% | $74 → $75 | Maintains | Strong Buy | Get Alert |
FAQ
What is the target price for Mirum Pharmaceuticals (MIRM) stock?
The latest price target for Mirum Pharmaceuticals (NASDAQ:MIRM) was reported by HC Wainwright & Co. on February 28, 2025. The analyst firm set a price target for $72.00 expecting MIRM to rise to within 12 months (a possible 64.80% upside). 29 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Mirum Pharmaceuticals (MIRM)?
The latest analyst rating for Mirum Pharmaceuticals (NASDAQ:MIRM) was provided by HC Wainwright & Co., and Mirum Pharmaceuticals maintained their buy rating.
When was the last upgrade for Mirum Pharmaceuticals (MIRM)?
There is no last upgrade for Mirum Pharmaceuticals
When was the last downgrade for Mirum Pharmaceuticals (MIRM)?
There is no last downgrade for Mirum Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Mirum Pharmaceuticals (MIRM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mirum Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mirum Pharmaceuticals was filed on February 28, 2025 so you should expect the next rating to be made available sometime around February 28, 2026.
Is the Analyst Rating Mirum Pharmaceuticals (MIRM) correct?
While ratings are subjective and will change, the latest Mirum Pharmaceuticals (MIRM) rating was a maintained with a price target of $66.00 to $72.00. The current price Mirum Pharmaceuticals (MIRM) is trading at is $43.69, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
